Cargando…

Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)

Ovarian cancer is a gynecological neoplasm that can be found in women, which, due to diagnostic difficulties, is often detected at advanced stages when treatment becomes a significant problem. Moreover, in a number of cases there is a cancer recurrence and resistance to standard chemotherapy treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Królewska-Daszczyńska, Patrycja, Wendlocha, Dominika, Smycz-Kubańska, Marta, Stępień, Sebastian, Mielczarek-Palacz, Aleksandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667454/ https://www.ncbi.nlm.nih.gov/pubmed/36406181 http://dx.doi.org/10.3892/ol.2022.13585

Ejemplares similares

The role of galectins-1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2022)

Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cancer
por: Smycz-Kubańska, Marta, et al.
Publicado: (2022)

Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer
por: Englisz, Aleksandra, et al.
Publicado: (2023)

Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand Inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2020)

Participation of Selected Soluble BMP-2 and BMP-7 Bone Morphogenetic Proteins and Their Soluble Type I ALK-1 and Type II BMPR2 Receptors in Formation and Development of Endometriosis
por: Janusz, Joanna, et al.
Publicado: (2021)

The Assessment of IL-21 and IL-22 at the mRNA Level in Tumor Tissue and Protein Concentration in Serum and Peritoneal Fluid in Patients with Ovarian Cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2021)

Selected Flavonols in Breast and Gynecological Cancer: A Systematic Review
por: Wendlocha, Dominika, et al.
Publicado: (2023)

The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis
por: Sikora, Justyna, et al.
Publicado: (2018)

The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
por: Stępień, Sebastian, et al.
Publicado: (2023)

Evaluation of the Potential Diagnostic Utility of the Determination of Selected Caspases—Markers Involved in the Regulation of Apoptosis—In Patients with Ovarian Cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2021)

Assessment of concentrations of sTRAIL ligand and its receptors sTRAIL-R1 and sTRAIL-R2 – markers monitoring the course of the extrinsic pathway of apoptosis induction: potential application in ovarian cancer diagnostics
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2015)

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2012)

MicroRNAs as Potential Biomarkers in Gynecological Cancers
por: Miśkiewicz, Joanna, et al.
Publicado: (2023)

Effect of Th1/Th2 cytokine administration on proinflammatory SKOV-3 cell activation
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2015)

The Role of Extracellular Matrix Proteins in Breast Cancer
por: Lepucki, Arkadiusz, et al.
Publicado: (2022)

Tumor Markers and Their Diagnostic Significance in Ovarian Cancer
por: Matsas, Alkis, et al.
Publicado: (2023)

Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance
por: Klemba, Aleksandra, et al.
Publicado: (2018)

Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
por: Kujawa, Katarzyna Aleksandra, et al.
Publicado: (2020)

Characteristics of in Vivo Model Systems for Ovarian Cancer Studies
por: Tudrej, Patrycja, et al.
Publicado: (2019)

Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
por: Terraneo, Nastassja, et al.
Publicado: (2020)

Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
por: Yang, Wookyeom, et al.
Publicado: (2021)

Markers of stem cells in human ovarian granulosa cells: is there a clinical significance in ART?
por: Varras, Michail, et al.
Publicado: (2012)

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
por: Ali, H Raza, et al.
Publicado: (2011)

Evaluation of the Role of ITGBL1 in Ovarian Cancer
por: Cortez, Alexander Jorge, et al.
Publicado: (2020)

The significance of markers in the diagnosis of endometrial cancer
por: Żyła, Monika M., et al.
Publicado: (2016)

Diagnostics and treatment of ovarian cancer in the era of precision medicine - opportunities and challenges
por: Bukłaho, Patrycja Aleksandra, et al.
Publicado: (2023)

Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers
por: Bane, Anita, et al.
Publicado: (2013)

Mesenchymal Stem Cell Microvesicles from Adipose Tissue: Unraveling Their Impact on Primary Ovarian Cancer Cells and Their Therapeutic Opportunities
por: Szyposzynska, Agnieszka, et al.
Publicado: (2023)

Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis
por: Iżycka, Natalia, et al.
Publicado: (2023)

New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
por: Muñoz-Galván, Sandra, et al.
Publicado: (2019)

GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer
por: Ha, Ji Hee, et al.
Publicado: (2021)

Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis
por: Zhang, Jing, et al.
Publicado: (2021)

Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer
por: Zhang, Xiaowei, et al.
Publicado: (2016)

Breast Cancers with Ocular Metastases are Early Onset, Non-Familial and Non-BRCA1/BRCA2 Tumours
por: Królewska, Katarzyna, et al.
Publicado: (2004)

Markers of Angiogenesis in Ovarian Cancer
por: Merritt, William M., et al.
Publicado: (2007)

Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
por: Zong, Xingyue, et al.
Publicado: (2019)

Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells
por: Lee, Heejin, et al.
Publicado: (2020)

Significance of stem cell marker Nanog gene in the diagnosis and prognosis of lung cancer
por: Liu, Zeng, et al.
Publicado: (2016)

Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022)

On the Significance of New Biochemical Markers for the Diagnosis of Premature Labour
por: Rzepka, Rafał, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hk3ckb1vd0mddq0gcltt262h1k